Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Pierre Jonville Bera

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Therapie|March 20, 2025
[Deleterious impact of a non-steroidal anti-inflammatory taken for fever or acute pain in case of streptococcal infection]Annie-Pierre Jonville-Bera, Joëlle Micallef
Presse Medicale (Paris, France : 1983)|September 3, 2011
[Adverse drug reactions of strontium ranelate(Protelos(®) in France]Annie-Pierre Jonville-Bera, Elisabeth Autret-Leca
Therapie|March 2, 2020
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance CentresClémence Lacroix, Michel Mallaret, Annie-Pierre Jonville-Bera
Therapie|June 22, 2007
Upper gastrointestinal complications associated with NSAIDs in childrenElisabeth Autret-Leca, Lamiae Bensouda-Grimaldi, Chantal Maurage, et al.
British Journal of Clinical Pharmacology|June 9, 2016
Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance databaseFlorentia Kaguelidou, Frédérique Beau-Salinas, Annie Pierre Jonville-Bera, et al.
Therapie|August 27, 2023
Drug-related hypophosphatemia: Descriptive study and case/non-case analysis of the French national pharmacovigilance databaseEve-Marie Thillard, Paula Sade, Joelle Michot, et al.
The Journal of Rheumatology|November 15, 2022
COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance StudyYanis Ramdani, Bérenger Largeau, Annie-Pierre Jonville-Bera, et al.
Pharmacy World & Science : PWS|April 17, 2004
A prescription and administration error of cisplatin: a case reportXavier Pourrat, Daniel Antier, Isabelle Crenn, et al.
Acta Dermato-Venereologica|November 27, 2015
Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic ReviewMarion Nadal, Bruno Giraudeau, Elsa Tavernier, et al.
Drug Safety|December 29, 2020
French Pharmacovigilance Public System and COVID-19 PandemicAurélie Grandvuillemin, Milou-Daniel Drici, Annie Pierre Jonville-Bera, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Therapie|March 20, 2025
[Deleterious impact of a non-steroidal anti-inflammatory taken for fever or acute pain in case of streptococcal infection]Annie-Pierre Jonville-Bera, Joëlle Micallef
Presse Medicale (Paris, France : 1983)|September 3, 2011
[Adverse drug reactions of strontium ranelate(Protelos(®) in France]Annie-Pierre Jonville-Bera, Elisabeth Autret-Leca
Therapie|March 2, 2020
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance CentresClémence Lacroix, Michel Mallaret, Annie-Pierre Jonville-Bera
Therapie|June 22, 2007
Upper gastrointestinal complications associated with NSAIDs in childrenElisabeth Autret-Leca, Lamiae Bensouda-Grimaldi, Chantal Maurage, et al.
British Journal of Clinical Pharmacology|June 9, 2016
Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance databaseFlorentia Kaguelidou, Frédérique Beau-Salinas, Annie Pierre Jonville-Bera, et al.
Therapie|August 27, 2023
Drug-related hypophosphatemia: Descriptive study and case/non-case analysis of the French national pharmacovigilance databaseEve-Marie Thillard, Paula Sade, Joelle Michot, et al.
The Journal of Rheumatology|November 15, 2022
COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance StudyYanis Ramdani, Bérenger Largeau, Annie-Pierre Jonville-Bera, et al.
Pharmacy World & Science : PWS|April 17, 2004
A prescription and administration error of cisplatin: a case reportXavier Pourrat, Daniel Antier, Isabelle Crenn, et al.
Acta Dermato-Venereologica|November 27, 2015
Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic ReviewMarion Nadal, Bruno Giraudeau, Elsa Tavernier, et al.
Drug Safety|December 29, 2020
French Pharmacovigilance Public System and COVID-19 PandemicAurélie Grandvuillemin, Milou-Daniel Drici, Annie Pierre Jonville-Bera, et al.
Pageof 4